Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

U.S. Stocks Decline on Apple Amid Government Budget Talks

Don't Miss Out —
Follow us on:
U.S. Stocks Decline on Apple Amid Government Budget Discussions
Apple Inc., the most valuable company, sank 3.8 percent as UBS AG cut its share-price estimate. Photographer: Simon Dawson/Bloomberg

Dec. 14 (Bloomberg) -- U.S. stocks fell, extending yesterday’s drop, as a slump in Apple Inc. and the federal budget stalemate offset an increase in industrial production and data showing China’s manufacturing may expand at a faster pace.

Apple, the most valuable company, sank 3.8 percent as UBS AG cut its share-price estimate. Best Buy Co. slumped 15 percent after extending founder Richard Schulze’s deadline to make an offer to take the company private. Smith & Wesson Holding Corp. slumped 4.3 percent as the killing of children at a Connecticut elementary school spurred speculation of tighter gun-control laws. U.S. Steel Corp. and Alcoa Inc. added more than 1.7 percent to pace gains in commodity companies.

The Standard & Poor’s 500 Index fell 0.4 percent to 1,413.58 at 4 p.m. New York time. The benchmark measure for American equities lost 0.3 percent this week. The Dow Jones Industrial Average slid 35.71 points, or 0.3 percent, to 13,135.01 today. About 5.8 billion shares changed hands on U.S. exchanges, or 6.7 percent below the three-month average.

“The chances of some type of grand bargain in Washington are significantly diminishing as time passes,” said Eric Teal, chief investment officer at First Citizens Bancshares Inc., which manages $4.5 billion in Raleigh, North Carolina. “On a company level, investors are looking at the competitive landscape for Apple and they see threats.”

Nine out 10 industries in the S&P 500 retreated as technology, the biggest group, led the losses. President Barack Obama and Republican House Speaker John Boehner remained deadlocked yesterday during their third White House meeting on next year’s budget.

Economic Data

In China, the December preliminary reading was 50.9 for a purchasing managers’ index released by HSBC Holdings Plc and Markit Economics, beating estimates. Industrial production in the U.S. rose in November by the most in two years.

“We’ve had further confirmation of a soft landing in China,” said Michael Strauss, who helps oversee about $26 billion as chief investment strategist at Commonfund in Wilton, Connecticut. He spoke in a phone interview. “That’s good for markets. Yet people are still worrying about the fiscal cliff. It’s going to be a 24th hour or overtime event.”

The S&P 500 has dropped 0.2 percent this month, paring its 2012 rally to 12 percent. Its average increase for December is 1.5 percent, the most of any month except July, according to data dating back to 1928 compiled by Bloomberg.

Apple sank 3.8 percent to $509.79. UBS cut its price estimate to $700 from $780, citing concern that growth may slow for the iPhone and iPad.

Apple Options

The cost of Apple options relative to other technology companies has risen to a four-year high, reflecting concern the iPhone and iPad maker’s dominance may be threatened by rivals such as Google Inc. and Nokia Oyj.

Implied volatility, which traders use to gauge option prices, for three-month contracts closest to Apple’s shares was 2.18 times more than the Technology Select Sector SPDR Fund last week, the highest level since September 2008, according to data compiled by Bloomberg. Apple shares have fallen 25 percent to $529.69 since a record high in September.

The options trading “is a reflection of market participants being a little bit more skeptical of Apple’s story going forward,” John Goltermann, who helps oversee $850 million at Obermeyer Asset Management Inc. in Aspen, Colorado, said in a phone interview on Dec. 12. His firm doesn’t own Apple shares. “The market is questioning what’s next on the innovation side and how they’re going to protect their margin.”

Best Buy

Best Buy slumped 15 percent to $12.05. Schulze can now make a proposal to buy the company from Feb. 1 through Feb. 28, Best Buy said today in a statement. The company agreed that it was in the best interest of shareholders to let Schulze and his partners include results from the holiday season in their due diligence review, the retailer said.

Smith & Wesson slumped 4.3 percent to $9.13 while Sturm Ruger & Co. dropped 4.5 percent to $45.57. President Obama said the Connecticut shooting, the most deadly in a string of mass killings this year, shows the nation must take “meaningful action” to stem such violence. Twenty-six people, including 20 children, died when a gunman walked into a Newtown, Connecticut, elementary school and opened fire this morning.

Schlumberger Ltd. dropped 5 percent to $68.91. The world’s largest oilfield-services provider said it expects earnings per share to fall because of delays and slowing activity in its two largest regional units.

Raw-material producers were the only group among 10 in the S&P 500 to gain as the S&P GSCI gauge of 24 commodities added 0.9 percent on bets that demand will increase in China. U.S. Steel rose 6.8 percent to $23.85. Alcoa increased 1.8 percent to $8.74.

Adobe Rallies

Adobe Systems Inc. added 5.7 percent to $37.56 after the software company reported fiscal fourth-quarter sales and profit that topped analysts’ estimates as customers embraced its flagship Creative Suite.

FuelCell Energy Inc. jumped 7.5 percent to 94 cents. The U.S. manufacturer of fuel-cell power plants surged on an agreement to build a 14.9-megawatt power plant in Connecticut for Dominion Resources Inc.

Boston Scientific Corp. gained 0.7 percent to $5.67. The seller of drug-coated stents was raised to overweight from underweight at Barclays Plc by equity analyst Matthew Taylor. The share-price estimate is $7.

To contact the reporter on this story: Rita Nazareth in New York at rnazareth@bloomberg.net

To contact the editor responsible for this story: Lynn Thomasson at lthomasson@bloomberg.net

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.